Evidence map›Paper›PMID 20889977›Full record

ArticleThe Journal of biological chemistry2010

Morphine modulation of thrombospondin levels in astrocytes and its implications for neurite outgrowth and synapse formation.

Hiroko Ikeda, Mayumi Miyatake, Noriaki Koshikawa, Kuniyasu Ochiai, Kiyoshi Yamada, Alexi Kiss, Maureen J Donlin, W Michael Panneton, James D Churchill, Michael Green and 7 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Astrocytic transcriptional and epigenetic mechanisms of drug addiction.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Astrocytes in Addictive Disorders.Advances in neurobiology · 2021
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

Hiroko IkedaE. A. Doisy Department of Biochemistry and Molecular Biology, St. Louis University, St. Louis, Missouri 63104, USA.
Mayumi Miyatake
Noriaki Koshikawa
Kuniyasu Ochiai
Kiyoshi Yamada
Alexi Kiss
Maureen J Donlin
W Michael Panneton
James D Churchill
Michael Green
Akbar M Siddiqui
Andrew L Leinweber
Nicholas R Crews
Lubov A Ezerskiy
Victoria R Rendell
Mariana M Belcheva
Carmine J Coscia
Saint Louis University · USNihon University · JP

Funding

OPIOID MODULATION OF ASTROCYTE PROLIFERATIONR01DA005412 · NIDA · SAINT LOUIS UNIVERSITY · PI COSCIA, CARMINE JAMES · 1987 to 2008
$2.3M
NIDA NIH HHS DA-005412NIDA NIH HHS R01 DA005412
6 · The paper itself

Abstract

Opioid receptor signaling via EGF receptor (EGFR) transactivation and ERK/MAPK phosphorylation initiates diverse cellular responses that are cell type-dependent. In astrocytes, multiple μ opioid receptor-mediated mechanisms of ERK activation exist that are temporally distinctive and feature different outcomes. Upon discovering that chronic opiate treatment of rats down-regulates thrombospondin 1 (TSP1) expression in the nucleus accumbens and cortex, we investigated the mechanism of action of this modulation in astrocytes. TSP1 is synthesized in astrocytes and is released into the extracellular matrix where it is known to play a role in synapse formation and neurite outgrowth. Acute morphine (hours) reduced TSP1 levels in astrocytes. Chronic (days) opioids repressed TSP1 gene expression and reduced its protein levels by μ opioid receptor and ERK-dependent mechanisms in astrocytes. Morphine also depleted TSP1 levels stimulated by TGFβ1 and abolished ERK activation induced by this factor. Chronic morphine treatment of astrocyte-neuron co-cultures reduced neurite outgrowth and synapse formation. Therefore, inhibitory actions of morphine were detected after both acute and chronic treatments. An acute mechanism of morphine signaling to ERK that entails depletion of TSP1 levels was suggested by inhibition of morphine activation of ERK by a function-blocking TSP1 antibody. This raises the novel possibility that acute morphine uses TSP1 as a source of EGF-like ligands to activate EGFR. Chronic morphine inhibition of TSP1 is reminiscent of the negative effect of μ opioids on EGFR-induced astrocyte proliferation via a phospho-ERK feedback inhibition mechanism. Both of these variations of classical EGFR transactivation may enable opiates to diminish neurite outgrowth and synapse formation.

Indexed as

AnimalsAstrocytesCell Line, TransformedCell ProliferationCerebral CortexEnzyme ActivationErbB ReceptorsExtracellular Signal-Regulated MAP KinasesMAP Kinase Signaling SystemMorphineNarcoticsNeuritesNucleus AccumbensRatsRats, Sprague-DawleyReceptors, Opioid, muEgfr protein, ratErbB ReceptorsExtracellular Signal-Regulated MAP KinasesMorphineNarcoticsReceptors, Opioid, muThrombospondin 1Transforming Growth Factor beta1

Identifiers

PMID20889977
PMCPMC2992274
OpenAlexW1969688763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.